China continues to see a large disparity of medical treatment costs in the private vs. public sector, which has been highlighted again this year, despite some reduction in treatment (claims) due to the COVID-19 pandemic. Overall, insurers in China continue to battle the rising costs, which are further compounded in specific regions and cities, such as Beijing - the most expensive city for treatment in the country according to many insurers.
As for the regional pricing adjustment strategies, insurers are developing virtual healthcare capabilities and forming key partnerships with medical facilities to address the increased medical costs, and collectively avoiding higher than normal increases for their members."
Jason Armer,
Country Manager at Pacific Prime China